🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Robot-assisted Walking Treatment in Hereditary Spastic Paraplegia (HSP)

Recruitingn/aAges 4 Years - 70 YearsAllIRCCS Eugenio Medea
NCT06728787 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Patients will undergo a combined rehabilitation treatment consisting of 15 sessions on Lokomat and 15 sessions of physical therapy over three weeks for a total of 30 sessions. Two sessions/day for 5 days a week. The same subjects will conduct clinical-functional assessments before, at the end of treatment, and after a 3-month follow-up: 3D Gait Analysis with defined protocol (BTSBioenginner); Spastic Paraplegia Rating Scale (SPRS); Six-Minute Walk Test (6MWT), Ten Meters Walk Test (10MWT), Gross Motor Function Measure-88 (GMFM-88) and Berg Balance Scale (BBS); Quality of life questionnaires: Medical Outcome Survey Short Form (SF-36) and ad hoc questionnaire for subjective assessment of symptoms during walking (HSP-SNAP). This study is part of normal clinical practice and does not involve any changes to the current rehabilitation course for patients.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * genetic or clinical diagnosis of HSP. * age greater than 4 years and less than 70 * femur length \> 23 cm * ability to walk independently indoors, with or without walking aids. Exclusion Criteria: * botulinum toxin injection or lower limb surgery in the previous 6 months * severe lower limb muscle retractions * severe osteoporosis * unhealed skin lesions in lower limbs * cardiovascular instability * acute or progressive neurological disorders * behavioral problemS
💊

What it tests

  • Robot-Assisted Gait Training
📍

Where

1 site
Irccs Eugenio Medea
Bosisio Parini, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy